Inhibition of Mcl-1 Enhances the Efficacy of Tyrosine Kinase Inhibition in FLT3 Mutated AML and Synergizes with Venetoclax Targeting AML Stem Cells

被引:0
作者
Carter, Bing Z. [1 ]
Tao, Wenjing [1 ]
Mak, Po Yee [1 ]
Zhang, Qi [2 ]
Wang, Xiangmeng [1 ]
Kuruvilla, Vinitha Mary [3 ]
Stewart, Carli [2 ]
Ruvolo, Vivian [1 ]
Battula, Venkata Lokesh [1 ]
Konopleva, Marina Y. [1 ]
Caenepeel, Sean [4 ]
Canon, Jude [4 ]
Hughes, Paul [4 ]
Morrow, P. K. [4 ]
Andreeff, Michael [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
关键词
D O I
10.1182/blood-2019-125725
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1267
引用
收藏
页数:4
相关论文
共 50 条
[41]   A combination of Dihydroartemisinin and Venetoclax enhances antitumor effect in AML via C-MYC/BCL-XL/MCL-1 triple targeting [J].
Li, Fenglin ;
Chen, Yao ;
Zhuang, Haihui ;
Pei, Renzhi ;
Lu, Yuyu ;
Chen, Dong ;
Li, Shuangyue ;
Ye, Peipei ;
Lian, Jiaying ;
Lu, Ying .
DISCOVER ONCOLOGY, 2025, 16 (01)
[42]   Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells [J].
Wang, Rui ;
Xia, Lijuan ;
Gabrilove, Janice ;
Waxman, Samuel ;
Jing, Yongkui .
CLINICAL CANCER RESEARCH, 2016, 22 (05) :1211-1221
[43]   Defined niche conditions and a stem cell phenotype both contribute to the in vitro resistance of primary AML cells to a FLT3 tyrosine kinase inhibitor [J].
Pallis, M. ;
Seedhouse, C. H. ;
Russell, N. H. ;
Mony, U. ;
Jawad, M. .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 :13-13
[44]   Targeting of MDS and AML Stem Cells Via Inhibition of STAT3 By Pyrimethamine [J].
Shastri, Aditi ;
Schinke, Carolina ;
Yanovsky, Asya Varshavsky ;
Bhagat, Tushar D. ;
Giricz, Orsolya ;
Barreyro, Laura ;
Boultwood, Jacqueline ;
Pellagati, Andrea ;
Yu, Yiting ;
Brown, Jennifer R. ;
Frank, David A. ;
Das, Bhaskar ;
Kambhampati, Suman ;
Will, Britta ;
Steidl, Ulrich ;
Verma, Amit .
BLOOD, 2014, 124 (21)
[45]   All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo [J].
Ma, Hayley S. ;
Greenblatt, Sarah M. ;
Shirley, Courtney M. ;
Duffield, Amy S. ;
Bruner, J. Kyle ;
Li, Li ;
Bao Nguyen ;
Jung, Eric ;
Aplan, Peter D. ;
Ghiaur, Gabriel ;
Jones, Richard J. ;
Small, Donald .
BLOOD, 2016, 127 (23) :2867-2878
[46]   The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML cells expressing a constitutively activated FLT3 [J].
Dirschinger, RJ ;
Schwab, R ;
Faber, F ;
Buske, C ;
Schnittger, S ;
Kelly, LM ;
Gilliland, DG ;
Hiddemann, W ;
Spiekermann, K .
EUROPEAN JOURNAL OF CANCER, 2002, 38 :S83-S84
[47]   Combinatorial Targeting of Leukemia and Stromal Cells Overcomes Fms-like Tyrosine Kinase 3 (FLT3) Inhibitor Resistance in Acute Myeloid Leukemia (AML) [J].
Bhattacharya, Seemana ;
Mu, Hong ;
Piya, Sujan ;
Zhang, Weiguo ;
McQueen, Teresa ;
Paradiso, Linda ;
Oberkovitz, Galia ;
Benami, Eyal ;
Andreeff, Michael ;
Borthakur, Gautam .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 :S273-S273
[48]   FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657 [J].
Goemans, Bianca F. ;
Zwaan, Christian M. ;
Cloos, Jacqueline ;
de Lange, Desiree ;
Loonen, Anne H. ;
Reinhardt, Dirk ;
Hahlen, Karel ;
Gibson, Brenda E. S. ;
Creutzig, Ursula ;
Kaspers, Gertjan J. L. .
LEUKEMIA RESEARCH, 2010, 34 (10) :1302-1307
[49]   ATRA can enhance apoptosis that is induced by Flt3 tyrosine kinase inhibition in Flt3-ITD positive cells [J].
Scholl, S ;
Müller, R ;
Clement, JH ;
Loncarevic, IF ;
Böhmer, FD ;
Höffken, K .
LEUKEMIA RESEARCH, 2006, 30 (05) :633-642
[50]   Discovery of a highly selective FLT3 inhibitor with specific proliferation inhibition against AML cells harboring FLT3-ITD mutation [J].
Heng, Hao ;
Zhi, Yanle ;
Yuan, Haoliang ;
Wang, Zhijie ;
Li, Hongmei ;
Wang, Shuxian ;
Tian, Jieyi ;
Liu, Haichun ;
Chen, Yadong ;
Lu, Tao ;
Ran, Ting ;
Lu, Shuai .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 163 :195-206